We are pleased to announce the addition of a leading life sciences patent litigation team led by Siegmund ("Sige") Gutman, a Los Angeles–based Member who serves as Chair of our Life Sciences Litigation Practice and Co-chair of our Patent Litigation Practice. Sige is joined by Member David Hanna and nearly a dozen attorneys based in Los Angeles, Boston, and New York.
Along with representing life sciences clients before trial and appellate courts as well as arbitration panels, Sige develops and executes market exclusivity and freedom to operate (FTO) strategies, including patent office and FDA regulatory strategies for leading biologics, pharmaceutical, biotechnology, and medical device clients. His background combines a graduate degree in molecular and cell biology and biophysical chemistry with more than 20 years of industry experience, including serving as senior patent litigation counsel for Amgen. He is consistently recognized as one of the top IP lawyers in California, and he has been recognized by Benchmark Litigation, The Legal 500 United States, and Chambers USA.
"Sige adds to our highly regarded IP practice a best-in-class, immensely respected life sciences litigation practice. That practice complements perfectly our life sciences transactional and patent prosecution practices, as well as our high-tech IP litigation practice," said Mintz's Managing Member Bob Bodian.
Member David Hanna focuses on biologic drug patent and Hatch-Waxman patent litigation on behalf of both patentees and generic filers. His biologics drug patent litigation experience includes litigating matters relating to Stelara®, Avastin®, and Herceptin®.
We invite you to learn more about Sige and David by clicking on the bio links below. To learn more about the team, please read our press release.
Meet Sige and David
Member / Chair, Life Sciences Litigation Practice;
Co-chair, Patent Litigation Practice
SGutman@mintz.com and 310.226.7866.
Member
DHanna@mintz.com and 310.226.7842.